CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 73 filers reported holding CHEMOCENTRYX INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $614,000 | +60.7% | 65,553 | +27.1% | 0.24% | +136.3% |
| Q4 2016 | $382,000 | +267.3% | 51,561 | +198.1% | 0.10% | +308.0% |
| Q3 2016 | $104,000 | +121.3% | 17,298 | +66.6% | 0.02% | +177.8% |
| Q2 2016 | $47,000 | -66.7% | 10,386 | -81.7% | 0.01% | -55.0% |
| Q1 2016 | $141,000 | +51.6% | 56,709 | +359.4% | 0.02% | +122.2% |
| Q1 2015 | $93,000 | -35.9% | 12,343 | -50.3% | 0.01% | -18.2% |
| Q2 2014 | $145,000 | – | 24,817 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |